Zhejiang Hengtong HoldingLtd Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Zhejiang Hengtong HoldingLtd şirketinin toplam hissedar öz sermayesi CN¥3.4B ve toplam borcu CN¥326.5M olup, bu da borç-öz sermaye oranını 9.6% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla CN¥4.4B ve CN¥957.0M dir. Zhejiang Hengtong HoldingLtd 'in FAVÖK'ü CN¥35.5M faiz karşılama oranı -0.2 dur. Şirketin CN¥807.9M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

9.6%

Borç/özkaynak oranı

CN¥326.48m

Borç

Faiz karşılama oranı	-0.2x
Nakit	CN¥807.95m
Eşitlik	CN¥3.41b
Toplam yükümlülükler	CN¥957.01m
Toplam varlıklar	CN¥4.36b

Son finansal sağlık güncellemeleri

Zhejiang Hengtong HoldingLtd (SHSE:600226) Seems To Use Debt Quite Sensibly

Jun 06

Does Zhejiang HugeleafLtd (SHSE:600226) Have A Healthy Balance Sheet?

Mar 06

Recent updates

There May Be Reason For Hope In Zhejiang Hengtong HoldingLtd's (SHSE:600226) Disappointing Earnings

Aug 29

Slowing Rates Of Return At Zhejiang Hengtong HoldingLtd (SHSE:600226) Leave Little Room For Excitement

Aug 07

Zhejiang Hengtong Holding Co.,Ltd.'s (SHSE:600226) Share Price Not Quite Adding Up

Jul 15

Zhejiang Hengtong HoldingLtd (SHSE:600226) Seems To Use Debt Quite Sensibly

Jun 06

Does Zhejiang HugeleafLtd (SHSE:600226) Have A Healthy Balance Sheet?

Mar 06

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 600226 'nin kısa vadeli varlıkları ( CN¥1.5B ) kısa vadeli yükümlülüklerini ( CN¥545.9M ) aşıyor.

Uzun Vadeli Yükümlülükler: 600226 şirketinin kısa vadeli varlıkları ( CN¥1.5B ) uzun vadeli yükümlülüklerini ( CN¥411.1M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 600226 şirketinin toplam borcundan daha fazla nakiti var.

Borcun Azaltılması: 600226 şirketinin borç/öz sermaye oranı son 5 yılda 8.3% seviyesinden 9.6% seviyesine yükseldi.

Borç Kapsamı: 600226 'nin işletme nakit akışı negatif olduğundan borçlar iyi karşılanamıyor.

Faiz Kapsamı: 600226 ödediğinden daha fazla faiz kazandırıyor, dolayısıyla faiz ödemelerinin karşılanması bir sorun teşkil etmiyor.

Zhejiang Hengtong HoldingLtd Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Zhejiang Hengtong HoldingLtd (SHSE:600226) Seems To Use Debt Quite Sensibly

Does Zhejiang HugeleafLtd (SHSE:600226) Have A Healthy Balance Sheet?

Recent updates

Third quarter 2024 earnings released: EPS: CN¥0.02 (vs CN¥0.02 in 3Q 2023)

Zhejiang Hengtong Holding Co.,Ltd. to Report Q3, 2024 Results on Oct 25, 2024

Investor sentiment improves as stock rises 25%

There May Be Reason For Hope In Zhejiang Hengtong HoldingLtd's (SHSE:600226) Disappointing Earnings

Second quarter 2024 earnings released: EPS: CN¥0.02 (vs CN¥0.056 in 2Q 2023)

Slowing Rates Of Return At Zhejiang Hengtong HoldingLtd (SHSE:600226) Leave Little Room For Excitement

Zhejiang Hengtong Holding Co.,Ltd.'s (SHSE:600226) Share Price Not Quite Adding Up

Zhejiang Hengtong Holding Co.,Ltd. (SHSE:600226) agreed to acquire the remaining 49% stake in Hengtong Precision Copper Foil Technology (Deyang) from Jiangsu Hengtong Precision Copper for CNY 290 million

Zhejiang Hengtong Holding Co.,Ltd. to Report First Half, 2024 Results on Aug 23, 2024

Zhejiang Hengtong HoldingLtd (SHSE:600226) Seems To Use Debt Quite Sensibly

First quarter 2024 earnings released: EPS: CN¥0.02 (vs CN¥0.01 in 1Q 2023)

Zhejiang Hengtong Holding Co.,Ltd., Annual General Meeting, May 16, 2024

Zhejiang Hugeleaf Co.,Ltd. to Report Q1, 2024 Results on Apr 23, 2024

Does Zhejiang HugeleafLtd (SHSE:600226) Have A Healthy Balance Sheet?

Zhejiang Hugeleaf Co.,Ltd. to Report Fiscal Year 2023 Results on Apr 23, 2024

Third quarter 2023 earnings released: EPS: CN¥0.02 (vs CN¥0.05 in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.056 (vs CN¥0.021 in 2Q 2022)

Zhejiang Hugeleaf Co.,Ltd. to Report First Half, 2023 Results on Aug 11, 2023

Full year 2022 earnings released: EPS: CN¥0.16 (vs CN¥0.12 in FY 2021)

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.05 (vs CN¥0.074 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.021 (vs CN¥0.03 in 2Q 2021)

Full year 2021 earnings released: EPS: CN¥0.12 (vs CN¥0.30 loss in FY 2020)

Less than half of directors are independent

Suzhou Haixia Dongrui Equity Investment Partnership Enterprise agreed to acquire 90% stake in Qingdao Hanquan Investment Co., Ltd. from Zhejiang Hugeleaf Co.,Ltd. (SHSE:600226) for CNY 170 million.

Third quarter 2021 earnings released: EPS CN¥0.074 (vs CN¥0.013 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.03 (vs CN¥0.032 in 2Q 2020)

Full year 2020 earnings released: CN¥0.30 loss per share (vs CN¥0.21 loss in FY 2019)

Hengtong Group Co., Ltd entered into a contract to acquire 4.99% stake in Qingdao Yebio Bioengineering Co., Ltd. from Zhejiang Hugeleaf Co.,Ltd. (SHSE:600226) for approximately CNY 290 million.

New 90-day high: CN¥2.11

New 90-day high: CN¥1.98

Third quarter earnings released

Zhejiang Hugeleaf Co.,Ltd. to Report Q3, 2020 Results on Oct 31, 2020

Earnings released

Zhejiang Hugeleaf Co.,Ltd. to Report First Half, 2020 Results on Aug 27, 2020

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin